Who has invested in Neogene Therapeutics?

No investors are named on the public record for Neogene Therapeutics yet.

Neogene Therapeutics Funding: $110M Raised, Series A

Neogene Therapeutics funding overview

Neogene Therapeutics is based in Philadelphia. Neogene Therapeutics has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A.

Neogene Therapeutics at a glance

Total raised: $110M
Latest round: Series A
Headquarters: Philadelphia

Frequently asked about Neogene Therapeutics funding

How much has Neogene Therapeutics raised?: Neogene Therapeutics has raised $110M in total disclosed funding across the rounds on record.
Who has invested in Neogene Therapeutics?: No investors are named on the public record for Neogene Therapeutics yet.
What was the latest Neogene Therapeutics funding round?: The most recent disclosed round is a Series A.
Where is Neogene Therapeutics based?: Neogene Therapeutics is based in Philadelphia.

Neogene Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Philadelphia below to benchmark round size and investor mix.

Neogene Therapeutics Funding: $110M Raised, Series A

Neogene Therapeutics funding overview

Neogene Therapeutics at a glance

Frequently asked about Neogene Therapeutics funding

Companies related to Neogene Therapeutics (18)

Browse related funding lists (2)